Production of a transgenic mosquito expressing circumsporozoite protein, a malarial protein, in the salivary gland of Anopheles stephensi (Diptera: Culicidae)

Acta Medica Okayama

Volumn 64, Issue 4, 2010, Pages 233-241

  Matsuoka, Hiroyuki ^a   Ikezawa, Tsunetaka ^a   Hirai, Makoto ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Flying syringe; Malaria; Salivary gland; Transgenic mosquito; Vaccine

Indexed keywords

CIRCUMSPOROZOITE PROTEIN, PROTOZOAN; GREEN FLUORESCENT PROTEIN; MALARIA VACCINE; PROTOZOAL PROTEIN; PROTOZOON ANTIBODY;

ANIMAL; ANOPHELES; ARTICLE; BAGG ALBINO MOUSE; FEMALE; GENETICS; METABOLISM; MOUSE; PLASMID; SALIVARY GLAND; TRANSGENIC ANIMAL;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; ANOPHELES; ANTIBODIES, PROTOZOAN; FEMALE; GREEN FLUORESCENT PROTEINS; MALARIA VACCINES; MICE; MICE, INBRED BALB C; PLASMIDS; PROTOZOAN PROTEINS; SALIVARY GLANDS;

ANOPHELES STEPHENSI; CULICIDAE; DIPTERA; MUS;

EID: 77956621193     PISSN: 0386300X     EISSN: 0386300X     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Clements AN: The adult salivary glands and their secretions; in The Biology of Mosquitoes, Chapman & Hall, London (1992) pp 251-262
2. Baume CA and Marin MC: Intra-household mosquito net use in Ethiopia, Ghana, Mali, Nigeria, Senegal, and Zambia: Are nets being used? Who in the household uses them? Am J Trap Med Hyg(2007) 77: 963-971
3. Fradin MS and Day JF: Comparative efficacy of insect repellents against mosquito bites. N Engl J Med (2002) 347: 13-18.
4. Vine JM: Malaria control with DDT on a national scale-Greece, 1946. Proc Roy Soc Med (1947) 40: 841-848.
5. Hemingway J, Field L and Vontas J: An overvew of insecticide resistance. Science (2002) 298: 96-97.
6. nd Ed, Cold Spring Harbor Laboratory Press, New York (1989) vol. 1-3.
7. Miller HI and Carter CA: Genetically engineered wheat, redux. Trend Biotech (2010) 28: 1-2.
8. Glaser S, Anastassiadis K and Stewart AF: Current issues in mouse genome engineering. Nat Genet (2005) 37: 1187-1193.
9. Lee BC, Kim MK, Jang G, Oh HJ, Yada F, Kim HJ, Shamin MH, Kim JJ, Kang SK, Schatten G and Hwang WS: Dogs cloned from adult somatic cells. Nature (2005) 436: 641-642.
10. Lieschke GJ and Currie PD: Animal models of human disease: zebrafish swim into view. Nat Rev Genetics (2007) 8: 353-367.
11. Horn C, Jaunich B and Wimmer EA: Highly sensitive, fluorescent transformation marker for Drosophila transgenesis. Dev Genes Evol (2000) 210: 623-629.
12. Goldsmith MR, Shimada T and Abe H: The genetics and genomics of the silkworm, Bobyx mori. Ann Rev Entomol (2004) 50: 71-100.
13. Alphey L, Beard CB, Billingsley P, Coetzee M, Crisanti A, Curtis C, Eggleston P, Godfray C, Hemingway J, Jacobs-Lorena M, James AA, Kafatos FC, Mukwaya LG, Paton M, Powell JR, Schneider W, Scott TW, Sina B, Sinden R, Sinkins S, Spielman A, Toure Y and Collins FH: Malaria control with genetically manipu lated insect vectors. Science (2002) 298: 119-121.
14. Nirmala X and James AA: Engineering Plasmodium-refractory phenotypes in mosquitoes. Trends Parasitol (2003) 19: 384-387.
15. Ito J, Ghosh A, Moreira LA, Wimmer EA and Jacobs-Lorena M: Transgenic anopheline mosquitoes impaired in transmission of a malaria parasite. Nature (2002) 417: 452-455.
16. Yoshida S, Shimada Y, Kondoh D, Kouzuma Y, Ghosh AK, Jacobs-Lorena M and Sinden RE: Hemolytic C-type lectin CEL-III from sea cucumber expressed in transgenic mosquitoes impairs malaria parasite development. PLoS Pathogens (2007) 3: 1962-1970.
17. James AA: Control of disease transmission through genetic modifi cation of mosquitoes; in Insect Transgenesis, Handler AM and James AA eds, CRC Press, Roca Raton, Florida (2000) pp 319-333
18. James AA: Molecular and biochemical analyses of the salivary glands of vector mosquitoes. Bull Inst Pasteur (1994) 92: 133-150.
19. Penneys NS, Nayar JK, Bernstein H, Knight JW and Leonardi C: Mosquito salivary gland antigens identified by circulating human antibodies. Arch Dermatol (1989) 125: 219-222.
20. Matsuoka H, Matsubara H, Waidhet P, Hashimoto T, Ishii A, Sato Y, Ando K and Chinzei Y: Depletion of salivary gland proteins in Anopheles stephensi (Diptera: Culicidae) on blood feeding, and induction of antibody to the proteins in mice being fed. Med Ent Zool (1997) 48: 211-218.
21. Crampton JM, Stowell SL, Karras M and Sinden RE: Model systems to evaluate the use of transgenic haematophagous insects to deliver protective vaccines. Parassitologia (1999) 41: 473-477.
22. Harada M, Ikeshoji T and Suguri S: Comparative study of the effect of using insecticide-impregnated bed nets and indoor residual spraying on malaria control in the Solomon Islands; in Malaria Research in The Solomon Islands, Ishii A, Nihei N and Sasa M eds, Inter Group Corporation, Tokyo (1998) pp 120-125
23. Molineaux L and Gramiccia: The Garki Project - Research on the epidemiology and control of malaria in the Sudan savanna of West Africa. The World Health Organization, Geneva (1980) pp 53-108.
24. Yoshida S, Sudo T, Niimi M, Tao L, Sun B, Kambayashi J, Watanabe H, Luo E and Matsuoka H: Inhibition of collageninduced platelet aggregation by anopheline antiplatelet protein, a saliva protein from a malaria vector mosquito. Blood (2008) 111: 2007-2014.
25. Nardin EH, Nussenzweig V, Nussenzweig R, Collins WE, Harinasta KT, Tapchaisri P and Chomcharn Y: Cirumsporozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J Exp Med (1982) 156: 20-30.
26. Dame JB, Williams JL, McCutchan TF, Weber JL, Wirtz RA, Hockmeyer WT, Maloy WL, Haynes JD, Schneider I, Roberts D, Sanders GS, Reddy EP, Diggs CL and Miller LH: Structure of the gene encoding the immunodominant surface antigen on the sporozoite of the human malaria parasite Plasmodium falciparum. Science (1984) 225: 593-599.
27. Eichinger DJ, Arnot DE, Tarn JP, Nussenzweig V and Enea V: Circumsporozoite protein of P. berghei: Gene cloning and identification of the immunodominant epitopes. Mol Cell Biol (1986) 6: 3965-3972.
28. Zavala F, Tarn JP, Barr PJ, Romero PJ, Ley V, Nussenzweig RS and Nussenzweig V: Synthetic peptide vaccine confers protection against murine malaria. J Exp Med (1987) 166: 1591-1596.
29. Stoute JA, Slaoui M, Heppner DG, Momin P, Kester KE, Desmons P, Wellde BT, Garcon N, Krzych U and Marchand M: A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. N Engl J Med (1997)336: 86-91.
30. Bejon P, Lusingu J, Olotu A, Leach A, Lievens M, Vekemans J, Mshamu S, Lang T, Gould J, Dubois MC, Demoitie MA, Stallaert JF, Vansadia P, Carter T, Njuguna P, Awuondo KO, Malabeja A, Abdul O, Gesase S, Mturi N, Drakeley CJ, Savarese B, Villafana T, Ballou WR, Cohen J, Riley EM, Lemnge MM, Marsh K and von Seidlein L: Efficacy of RTS, S/AS01E vaccine against malaria in children 5 to 17 months of age. New Engl J Med (2008) 359: 2521-2532.
31. Yoshida S, Kondoh D, Arai E, Matsuoka H, Seki C, Tanaka T, Okada M and Ishii A: Baculovirus virions displaying Plasmodium berghei circumsporozoite protein protect mice against malaria sporozoite infection. Virol (2003) 316: 161-170.
32. Catteruccia F, Nolan T, Loukeris TG, Blass C, Savakis C, Kafatos FC and Crisanti A: Stable germline transformation of the malaria mosquito Anopheles stephensi. Nature (2000) 405: 959-962.
33. Yoshida S and Watanabe H: Robust salivary gland-specific transgene expression in Anopheles stephensi mosquito. Insect Mol Biol (2006) 15: 403-410.
34. Hochstrasser H: Ubiquitin, proteasomes, and the regulation of intracellular protein degradation. Curr Opin Cell Biol (1995) 7: 215-223.
35. Fallon AM and Witthuhn BA: Proteasome activity in a naive mos quito cell line infected Walbachia pipientis wAlbB. In Vitro Cell Dev Biol (2009) 45: 460-466.